Direct Radionuclide Cystoureterography (DRCG), also referred to as DRC scan or DRCUG scan, is a specialized nuclear medicine imaging procedure used to detect vesicoureteral reflux (VUR)—a condition in which urine flows backward from the bladder into the ureters and sometimes up to the kidneys. This condition is especially common in infants and children and is a major cause of recurrent urinary tract infections (UTIs) and kidney damage in the pediatric population. The DRCG scan is a sensitive, accurate, and low-radiation test that provides real-time functional imaging of the bladder and ureters during urination. It is considered one of the best tools for monitoring reflux and evaluating the effectiveness of medical or surgical treatment.
What is Vesicoureteral Reflux (VUR)?
Vesicoureteral reflux (VUR) is a urological disorder where urine travels in the wrong direction—from the bladder up toward one or both ureters and sometimes into the kidneys. Normally, the urine should flow only one way—from the kidneys to the bladder—but in VUR, the valve mechanism fails, allowing reverse flow. Over time, this abnormal flow of urine can lead to kidney infections, renal scarring, hydronephrosis, and even permanent kidney damage if left undiagnosed and untreated. Diagnosing VUR early is critical, especially in children, to preserve long-term kidney function.
What is a DRCG Scan?
Direct Radionuclide Cystoureterography (DRCG) is a dynamic imaging study that evaluates the presence and severity of urinary reflux. It involves instilling a radiotracer-labeled fluid directly into the bladder via a catheter and capturing images with a gamma camera as the bladder fills and the patient voids (urinates).
This test offers high sensitivity in detecting even low-grade reflux episodes that may not be visible with conventional radiologic studies, such as voiding cystourethrography (VCUG). Importantly, the DRCG scan uses significantly lower radiation, making it ideal for repeated follow-up assessments, especially in children.
Why is a DRC Scan Performed?
The main objective of the DRCG scan is to diagnose or monitor VUR in patients with urinary tract symptoms, especially in the pediatric group. It also plays a pivotal role in guiding treatment decisions and assessing the success of anti-reflux surgery or medical management.
Common Indications for DRCG Scan:
Evaluation of vesicoureteral reflux (VUR)
Recurrent urinary tract infections (UTIs) in infants or children
Follow-up after reflux treatment (surgical or non-surgical)
Postnatal assessment in children with antenatally detected hydronephrosis
Screening of siblings or children of patients with known VUR
Unexplained kidney scarring or abnormal ultrasound findings
Evaluation of bladder dysfunction associated with reflux
How is the DRCG Scan Performed?
The DRC scan is generally performed in a nuclear medicine department under the supervision of a nuclear medicine physician and trained technologists. The scan is non-invasive except for the catheter insertion, which may cause minor discomfort.
Step-by-Step Procedure:
Patient Preparation
No fasting is needed
The procedure is explained in detail to the parent/patient
Written consent is taken, especially in pediatric cases
In younger children, mild sedation may be considered if required
Catheterization and Radiotracer Instillation
A soft urinary catheter is gently inserted into the bladder
The bladder is filled slowly with a sterile solution containing a small amount of radioactive tracer (commonly 99mTc-DTPA or 99mTc-sulfur colloid)
Image Acquisition
Dynamic imaging is performed with a gamma camera while the bladder is filling
The camera continues to record during voiding (urination) to assess for reflux
The process takes around 30 to 60 minutes, depending on the bladder filling and cooperation
Post-Test Care
The catheter is removed after the test
The patient is observed for any discomfort or urinary complaints
Normal activities can be resumed immediately afterward
What Does the DRCG Scan Show?
The DRC scan provides detailed functional images that help in detecting:
Presence or absence of VUR
Laterality (unilateral or bilateral reflux)
Grade of reflux (though not numerically graded like in VCUG, severity can be inferred)
Bladder dynamics during filling and voiding
Early or delayed reflux during different phases of the scan
Changes in reflux pattern after treatment
Who Should Avoid the Test?
While the DRCG scan is very safe, some conditions may warrant caution:
Patients with active urinary tract infections should be treated first
Children with severe urethral strictures or obstructions
Patients with known allergic reactions to radiotracers (very rare)
Pregnant women should avoid this test
Benefits of the DRC Scan
High sensitivity in detecting low-volume reflux
Minimal radiation, ideal for children and follow-up
Provides real-time assessment of bladder and ureter function
Safe, well-tolerated, and simple to perform
Allows monitoring of treatment outcomes
Suitable for large-scale pediatric screening in at-risk families
Conclusion
Direct Radionuclide Cystoureterography (DRCG scan) is a safe, sensitive, and low-radiation diagnostic procedure that plays an essential role in identifying vesicoureteral reflux (VUR). It offers superior sensitivity in detecting even subtle reflux episodes and is considered the test of choice for follow-up evaluations in children with recurrent UTIs or previously diagnosed VUR. By using functional imaging of urine flow during bladder filling and voiding, DRCG scans help clinicians make informed decisions regarding medical therapy, surgical interventions, and long-term monitoring. Its non-invasive nature, quick execution, and reliability make it a valuable tool in both pediatric and adult urological diagnostics.
Test information: Fasting NOT needed
Reporting: Within 2 hours*
NO fasting is needed.
The patient is advised to get urinary bladder catheterization from a nearby hospital under aseptic conditions using an appropriate size catheter or feeding tube.
Please carry all medical documents, including doctor referrals, previous reports, etc.
Female patients are to inform their status of pregnancy and lactation.
उपवास की आवश्यकता नहीं है।
रोगी को सलाह दी जाती है कि उचित आकार के कैथेटर या फीडिंग ट्यूब का उपयोग करके मूत्राशय कैथीटेराइजेशन, पास के अस्पताल से लगा के आए।
कृपया डॉक्टर रेफरल, पिछली रिपोर्ट आदि सहित सभी चिकित्सा दस्तावेज साथ रखें।
महिला रोगियों को अपनी गर्भावस्था और स्तनपान की स्थिति के बारे में सूचित करना होता है।
After registration and payment, the patient's medical history is taken, including checking referral, medical & surgical treatment details, investigation records, etc. Informed consent is also obtained at the same time.
The radiopharmaceutical is administered aseptically into the bladder via a urinary catheter, followed by an appropriate volume of sterile normal saline until the bladder reaches capacity.
The patient is asked to pass the urine in front of the Gamma Camera to see any reflux.
During the process of passing urine, continuous dynamic images are taken.
Procedure may take a total of up to 30 min.
* For details, please see service-related policies
You’ve added DRCG (Direct-radionuclide cysto-ureterography) scan to your cart